• Share
  • Email
  • Embed
  • Like
  • Save
  • Private Content
Neuroplasticity Therapy for Cognitive Disorders, pitch at JADE-INNOVage 11.6.2013
 

Neuroplasticity Therapy for Cognitive Disorders, pitch at JADE-INNOVage 11.6.2013

on

  • 477 views

Computer Enable Neuroplasticity Therapy for cognitive disorders uses real-time digital technology to measure electrical activity of the brain and present this information in a form that enables the ...

Computer Enable Neuroplasticity Therapy for cognitive disorders uses real-time digital technology to measure electrical activity of the brain and present this information in a form that enables the individual to perceive changes in the state of the brain and learn to modify abnormal patterns.

Statistics

Views

Total Views
477
Views on SlideShare
477
Embed Views
0

Actions

Likes
0
Downloads
0
Comments
0

0 Embeds 0

No embeds

Accessibility

Categories

Upload Details

Uploaded via as Microsoft PowerPoint

Usage Rights

CC Attribution License

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Processing…
Post Comment
Edit your comment
  • Prepare 10 minutes presentation by using this templateUse the following structure and order of 9 slides and fill in the content to each page to answer the questions (remove questions)You may use text, graphics, tables etc.Modify slide headings where neededFinal slide is free-to-useMaximum of 10 slides allowed in the presentation in addition to cover page. USE YOUR OWN SLIDE TEMPLATE / LOGOS / PICTURES AS NEEDEDRemove this page from your final presentation
  • Maksutonpalveluohjausjärjestelmä (verkkosivut, verkkoneuvonta, puhelinneuvonta, hakukone- jasosiaalisen median etsivätyö)ItsekehitettyverkkoasiointijärjestelmäasiakkaillejakumppaneilleItsekehitettyverkkopotilastietojärjestelmäpsykoterapeuteillejapsykiatreilleYhteisöllisyystehostaamarkkinoinnin, hallinnon, tukipalveluidensekätilojenjakalusteidenkäyttöäVideovalvontajahälytettävävartiontiparantaatyö- japotilasturvallisuuttaPsykoterapiakeskuksenkonseptikuvattuhelpostimonistettavaksijaperehdytettäväksi
  • Potilaanpäähänasetettavallamyssyllämitataanaivosähkötoimintaa (EEG) samalla, kun tietokoneohjelmaesittääpotilaalletietoahänenaivotoiminnastaanjakannustaamuuntamaansitäpelimäisestisuotuisampaansuuntaan. Terapiajaksokoostuuyhteensä 40 terapiaistunnosta, joitajärjestetäänviikossa on 3-4 kpl. Yksiterapiaistuntokestää 45 minuuttia. Terapiajaksokokonaisuudessaankestää 2-3 kuukautta. 60 potilaanlaajuinentutkimusohjelmanensimmäisettuloksetsaadaanvuoden 2012 lopulla, jonkajälkeenarvioidaanmenetelmänsoveltuvuuslaajempaanpotilaskäyttöön.HelsinginYliopisto, Swiss Federal Institute of Technology, University of Twentesekä The Health Care Service of Castilla-La Mancha (Espanja) ovatjättäneetkanssamme EU-tutkimusrahoitushakemuksenmenetelmänsoveltamisestamuidenkognitiivistenhäiriöidenehkäisyissä
  • Terapiajaksokestää 40 krt x 45 min terapiaistunnosta, joitajärjestetään 3-4 kplviikossa 2-3 kuukaudenajan.

Neuroplasticity Therapy for Cognitive Disorders, pitch at JADE-INNOVage 11.6.2013 Neuroplasticity Therapy for Cognitive Disorders, pitch at JADE-INNOVage 11.6.2013 Presentation Transcript

  • 20 % OF PEOPLEIS SUFFERINGFROM MENTALDISORDERLESS THAN 50 %OF MENTALDISORDERS ARETREATEDMENTALDISORDERDOUBLES THERISK OFUNEMPLOYMENTMOST MENTALDISORDERS COULDBE TREATEDOR PREVENTEDChairman Ville Tapio11.6.2013 JADE-INNOVage Joint EventNeuroplasticity Therapyby Mental Capital Care Ltd
  • Psychotherapy Center Vastaamo Started-up in late 2011 100 % owned by the family working in thecompany (Ville, Nina and Perttu Tapio) 38 psychotherapists, psychologist orpsychiatrists 1 150 private customers, 8 municipalities, 7associations and 2 hospital districts 16 reception rooms in the first psychotherapycenter in Helsinki Serving rest of the country with e-mentalhealth technology (video and text based) Expanding the network of psychotherapycenters to the biggest cities in Finland andthen to other Nordic countries
  • CENT Research Program 2011-2013 Computer Enable Neuroplasticity Therapyfor cognitive disorders A joint research project with universitiesof Helsinki and Erlange. Research grant of 790 000 € by Tekes (theFinnish Funding Agency for Research &Innovation). A pilot group of 40 ADHD/ADD patientsvalidated the method during Q3-4/2012. Commercial pilot to be launched inQ2/2013
  • Computer Enabled NeuroplasticityTherapyNeuroplasticity therapy uses real-time digital technology to measureelectrical activity of the brain and present this information in a form thatenables the individual to perceive changes in the state of the brain and learnto modify abnormal patterns.
  • Benefits Compared to Medication Efficiency Lack of adverse effects Long-lasting orpermanent results Cost-savings
  • Preliminary Results of theTreatment of 40 Research Patients
  • Treatable Disorders ADD/ADHD/Conduct issues Addictions/Addictive behavior Anxiety/Panic Attacks Autism Depression Epilepsy/Seizures Fibromyalgia Headaches (Migraine, Clusterand Tension) Head Injury Symptoms Insomnia PTSD Symptoms of Alzheimer’s”Neurofeedback is on thecutting edge of the mind-bodyrevolution. I believe it is oneof the treatments that willkeep us moving toward an eraof new approaches ofnaturally managing ourhealth.”- Candace B. Pert, former chief of BrainBiochemistry at the National Institute ofMental Health (USA)
  • Realiability ”Biofeedback helps treat some illness and may boost performance.”,American Psycological Association ”Neurofeedback always should be considered as an intervention forsome disorders”, American Academy of Child and Adolescent Psychiatry ”The therapy most promising by recent clinical trials appears to beEEG biofeedback.”, Current Opinion in Pediatrics –Magazine ”The literature, which lacks any negative study of substance, suggeststhat neurofeedback therapy should play a major therapeutic role inmany difficult areas. In my opinion, if any medication haddemonstrated such a wide spectrum of efficacy, it would beuniversally accepted and widely used.”, Frank H. Duffy, Professor,Harvard Medical School
  • THANK YOU!Mental Capital Care Ltdwww.mentalcapitalcare.comChairman Ville Tapioville.tapio@mentalcapitalcare.com+358 405909385